07:00 , Jun 23, 2008 |  BC Week In Review  |  Company News

Calypte management update

Calypte Biomedical Corp. (OTCBB:CBMC), Lake Oswego, Ore.   Business: Diagnostic   Hired: Donald Taylor as president and CEO, while remaining CEO of Swivel Secure Ltd.; he replaces Roger Gale, who will remain chairman  ...
07:00 , Aug 13, 2007 |  BC Week In Review  |  Company News

Calypte management update

Calypte Biomedical Corp. (CBMC), Lake Oswego, Ore.   Business: Diagnostic   Hired: J. Daniel Clark as VP of sales and marketing, formerly a consultant  ...
07:00 , Jul 16, 2007 |  BC Week In Review  |  Clinical News

Aware HIV-1/2 OMT regulatory update

CBMC received Indian marketing approval for its Aware HIV-1/2 OMT, an in vitro point-of-care immunoassay to detect HIV-1 and HIV-2 antibodies in oral fluid samples. Calypte Biomedical Corp. (CBMC), Lake Oswego, Ore.   Product: Aware...
07:00 , Jul 16, 2007 |  BC Week In Review  |  Company News

Calypte diagnostic news

CBMC will move to Portland, Ore., in September. Calypte Biomedical Corp. (CBMC), Lake Oswego, Ore.   Business: Diagnostic  ...
07:00 , May 28, 2007 |  BioCentury  |  Regulation

SOX clock countdown

Time has run out for the smallest public companies, which have not yet had to file their financial reports in accordance with the internal controls requirements of Section 404 of the Sarbanes-Oxley Act. Despite repeated...
07:00 , May 21, 2007 |  BC Week In Review  |  Company News

Calypte board of directors update

Calypte Biomedical Corp. (CBMC), Lake Oswego, Ore.   Business: Diagnostic   Appointed: Adel Karas, regional director for the World Agency of Planetary Monitoring & Earthquake Risk Reduction (WAPMERR)  ...
07:00 , May 22, 2006 |  BC Week In Review  |  Company News

Calypte management update

Calypte Biomedical Corp. (HIV), Lake Oswego, Ore.   Business: Diagnostic   Transition: Roger Gale to president and CEO from interim CEO, while remaining HIV's chairman  ...
07:00 , Apr 24, 2006 |  BioCentury  |  Regulation

Darning SOX

An SEC advisory committee last week wrapped up a year of work by recommending that the commission enact measures that could slash the expense of complying with the Sarbanes-Oxley Act for most public biotech companies....
07:00 , Apr 3, 2006 |  BC Week In Review  |  Company News

Calypte, Beijing Marr Bio-Pharmaceutical Co. Ltd. deal

HIV acquired a 51% stake in Beijing Marr Bio-Pharmaceutical for an undisclosed sum. Marr Technologies BV, HIV's largest stockholder, owns the remaining 49% of Beijing Marr. HIV said the deal gives it rights to manufacturing...
08:00 , Jan 16, 2006 |  BC Week In Review  |  Clinical News

Aware HIV-1/2 OMT regulatory update

The Beijing Drug Administration (BDA) of the State Food and Drug Administration (SFDA) of China accepted for review a registration application for Aware HIV-1/2 OMT, an oral fluid test, to diagnose HIV. Calypte Biomedical Corp....